Skip to main content

Find Clinical Trials

Home
Conditions
Hepatocellular Carcinoma (HCC)

Clinical trial condition

Hepatocellular Carcinoma (HCC)

Explore clinical trials studying Hepatocellular Carcinoma (HCC). Study availability and eligibility vary by location and protocol.

243 public trials 102 recruiting studies

Refine in advanced search Browse all conditions

Hepatocellular Carcinoma (HCC) trial results

Completed

Immune Checkpoint Inhibitors and Anti-vascular Endothelial Growth Factor Antibody/Tyrosine Kinase Inhibitors With or Without HAIC for Unresectable HCC With Portal Vein Tumor Thrombosis

NCT06881433

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Zhongda Hospital Nanjing, Jiangsu, China

View Trial Details

Completed

Immune Checkpoint Inhibitors and Anti-vascular Endothelial Growth Factor Antibody/Tyrosine Kinase Inhibitors With or Without TACE for Advanced HCC With Vascular Invasions

NCT06881446

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Zhongda Hospital Nanjing, Jiangsu, China

View Trial Details

Completed

IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC)

NCT03753659

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Hannover Medical School Hanover, Lower Saxony, Germany

View Trial Details

Completed

Individualized Surgical Guidance in HCC-BDTT

NCT07483242

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: China, Guangdong Guangzhou, Guangdong, China

View Trial Details

Completed

CECT Features of MVI Predict Response to TACE Plus TKI in Intermediate-stage HCC

NCT07449065

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
Locations: The First Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Completed

Effect of Pre-Transplant Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma Patients With Liver Transplantation

NCT07418138

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
Locations: First Affiliated Hospital Xian Jiaotong University Xi'an, Shaanxi, China

View Trial Details

Completed

The Effectiveness and Safety in High-risk Patients Receiving First-line Atezolizumab and Bevacizumab Combined With HAIC for HCC: a Retrospective Study

NCT07272265

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Completed

Interventional AI-Human Collaboration for Liver Tumor Diagnosis

NCT07153783

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +19 more
Locations: Shengjing Hospital of China Medical University Shenyang, Liaoning, China

View Trial Details

Completed

A Study of Tislelizumab Versus Sorafenib in Participants With Unresectable Hepatocellular Carcinoma (HCC)

NCT03412773

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Providence Medical Foundation Fullerton, California, United States

UCLA Hematologyoncology Los Angeles, California, United States

Chao Family Comprehensive Cancer Center Orange, California, United States

Massachusetts General Hospital Boston, Massachusetts, United States

View all 122 locations

View Trial Details

Completed

AI Multitask Model for HCC Treatment

NCT07157085

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Guangzhou, Guangdong, China

View Trial Details